A new medical device company in Kalamazoo plans to begin building a business around a product acquired from Stryker Corp. to treat a painful and potentially life-threatening condition.
Stryker Corp. has completed the acquisition of Arrinex Inc., a Menlo Park, Calif.-based medical device company that developed a treatment for chronic rhinitis.
KALAMAZOO — Two deals that closed in recent weeks typify medical device firm Stryker Corp.’s acquisition strategy.
Stryker Corp.’s sales grew nearly 8 percent during the third quarter to $3.24 billion. The quarterly result compares to sales of $3 billion in the same period last year.
Stryker Corp. acquired Durham, N.C.-based HyperBranch Medical Technology Inc. for $220 million.
Stryker Corp. signed a deal to pay $1.4 billion to acquire Leesburg, Va.-based K2M Group Holdings Inc., a maker of spinal devices.